Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 9.


Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao ORCID: 0000-0002-5489-6450, Reynolds, Helen ORCID: 0000-0001-7443-4520, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan
et al (show 18 more authors) (2022) 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. LANCET HIV, 9 (8). E534-E543.


Back, David, Marzolini, Catia, Hodge, Catherine, Marra, Fiona ORCID: 0000-0003-1326-1149, Boyle, Alison, Gibbons, Sara, Burger, David and Khoo, Saye
(2021) COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (1). pp. 212-213.


van der Wekken-Pas, Lena, Nassiwa, Sylvia, Malaba, Thokozule, Lamorde, Mohammed, Myer, Landon, Waitt, Catriona ORCID: 0000-0003-0134-5855, Reynolds, Helen ORCID: 0000-0001-7443-4520, Khoo, Saye, He, Nengjie, van Leeuwen, Liesbeth
et al (show 3 more authors) (2024) Comparison of dolutegravir- and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV; a DolPHIN2 substudy. AIDS (London, England).


Kintu, Kenneth, Malaba, Thokozile, Nakibuka, Jesca, Papamichael, Christiana, Colbers, Angela, Byrne, Kelly, Seden, Kay, Hodel, Eva Maria ORCID: 0000-0001-5821-1685, Chen, Tao ORCID: 0000-0002-5489-6450, Twimukye, Adelline
et al (show 11 more authors) (2020) Dolutegravir versus efavirenz when starting HIV therapy in late pregnancy: a randomised controlled trial. The Lancet HIV, 7 (5). e332-e339.


Hodge, Daryl ORCID: 0000-0003-2288-7020, Marra, Fiona ORCID: 0000-0003-1326-1149, Marzolini, Catia, Boyle, Alison, Gibbons, Sara, Siccardi, Marco ORCID: 0000-0002-3539-7867, Burger, David, Back, David and Khoo, Saye
(2020) Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (12). pp. 3417-3424.


Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Walker, A Sarah, Owen, Andrew ORCID: 0000-0002-9819-7651, Gibb, Diana M, Burger, David
et al (show 2 more authors) (2017) Effect of diurnal variation, <i>CYP2B6</i> genotype and age on the pharmacokinetics of nevirapine in African children. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72 (1). pp. 190-199.


Marra, Fiona ORCID: 0000-0003-1326-1149, Smolders, Elise J, El-Sherif, Omar, Boyle, Alison, Davidson, Katherine, Sommerville, Andrew J, Marzolini, Catia, Siccardi, Marco ORCID: 0000-0002-3539-7867, Burger, David, Gibbons, Sara
et al (show 2 more authors) (2021) Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. DRUGS IN R&D, 21 (1). pp. 9-27.


Marzolini, Catia, Kuritzkes, Daniel R, Marra, Fiona, Boyle, Alison, Gibbons, Sara, Flexner, Charles, Pozniak, Anton, Boffito, Marta, Waters, Laura, Burger, David
et al (show 2 more authors) (2022) Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications. CLINICAL PHARMACOLOGY & THERAPEUTICS, 112 (6). pp. 1191-1200.


Bienczak, Andrzej, Cook, Adrian, Wiesner, Lubbe, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Mulenga, Veronica, Kityo, Cissy, Kekitiinwa, Addy, Owen, Andrew ORCID: 0000-0002-9819-7651, Walker, A Sarah, Gibb, DianaM
et al (show 3 more authors) (2016) The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 82 (1). pp. 185-198.

This list was generated on Mon Mar 25 10:47:37 2024 GMT.